Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CFN Enterprises (CNFN) Accumulated Expenses (2020 - 2025)

CFN Enterprises' Accumulated Expenses history spans 6 years, with the latest figure at $3.4 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $3.4 million for Q4 2025, down 47.92% from a year ago — trailing twelve months through Dec 2025 was $3.4 million (down 47.92% YoY), and the annual figure for FY2025 was $3.4 million, down 47.92%.
  • Accumulated Expenses for Q4 2025 was $3.4 million at CFN Enterprises, down from $7.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $7.2 million in Q3 2025 to a low of $1.7 million in Q4 2021.
  • The 5-year median for Accumulated Expenses is $3.4 million (2023), against an average of $4.0 million.
  • The sharpest move saw Accumulated Expenses skyrocketed 204.29% in 2021, then tumbled 47.92% in 2025.
  • Year by year, Accumulated Expenses stood at $1.7 million in 2021, then surged by 39.9% to $2.3 million in 2022, then surged by 63.34% to $3.8 million in 2023, then surged by 72.27% to $6.6 million in 2024, then tumbled by 47.92% to $3.4 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $3.4 million, $7.2 million, and $7.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.